- ICH GCP
- EU Clinical Trials Registry
Clinical Trial Page
Clinical Trial Results:
A multi-national, multi-centre, randomized, parallel-group, double-blind study to compare the efficacy, tolerability and safety of Glatiramer Acetate Injection 40 mg/ml to that of Glatiramer Acetate Injection 20 mg/ml administered once daily by subcutaneous injection in subjects with relapsing remitting (RR) Multiple Sclerosis (MS)
Summary | |
EudraCT number | 2006-002037-20 |
Trial protocol | HU FI ES BE GB LV CZ IT LT DE EE |
Global completion date | 19 Nov 2008 |
Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
Results information | |
Results version number | v1(current) |
This version publication date | 28 Dec 2016 |
First version publication date | 28 Dec 2016 |
Other versions | |
Summary report(s) | GA-9016 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.